Skip to main content
icon for ¿Casos de sarampión en EE. UU. para el 30 de septiembre?

¿Casos de sarampión en EE. UU. para el 30 de septiembre?

icon for ¿Casos de sarampión en EE. UU. para el 30 de septiembre?

¿Casos de sarampión en EE. UU. para el 30 de septiembre?

NUEVO
30 sep 2026
Polymarket

$1,253 Vol.

Polymarket

2900+

$940 Vol.

98%

3000+

$313 Vol.

94%

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission in the US, driven by sub-95% MMR vaccination coverage and multiple persistent outbreaks, is pushing cumulative 2026 case counts well above prior years. As of August 20, the CDC reported 2,777 confirmed cases across 47 jurisdictions, with 94% in unvaccinated or unknown-status individuals, 66% among children and teens, and 94% outbreak-linked; Pennsylvania and Ohio added the largest recent weekly increments. School reopenings in late August and September are expected to accelerate spread in under-vaccinated communities, while weekly CDC surveillance updates will provide the authoritative counts used for resolution. Historical elimination status reviews underscore how sustained chains of transmission threaten official benchmarks.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$1,253
Fecha de finalización
30 sep 2026
Mercado abierto
Aug 24, 2026, 11:00 AM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.Ongoing measles transmission in the US, driven by sub-95% MMR vaccination coverage and multiple persistent outbreaks, is pushing cumulative 2026 case counts well above prior years. As of August 20, the CDC reported 2,777 confirmed cases across 47 jurisdictions, with 94% in unvaccinated or unknown-status individuals, 66% among children and teens, and 94% outbreak-linked; Pennsylvania and Ohio added the largest recent weekly increments. School reopenings in late August and September are expected to accelerate spread in under-vaccinated communities, while weekly CDC surveillance updates will provide the authoritative counts used for resolution. Historical elimination status reviews underscore how sustained chains of transmission threaten official benchmarks.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volumen
$1,253
Fecha de finalización
30 sep 2026
Mercado abierto
Aug 24, 2026, 11:00 AM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

Cuidado con los enlaces externos.

Preguntas frecuentes

"¿Casos de sarampión en EE. UU. para el 30 de septiembre?" es un mercado de predicción en Polymarket con 2 resultados posibles donde los operadores compran y venden acciones según lo que creen que sucederá. El resultado líder actual es "2900+" con 98%, seguido de "3000+" con 94%. Los precios reflejan probabilidades en tiempo real de la comunidad. Por ejemplo, una acción cotizada a 98¢ implica que el mercado colectivamente asigna una probabilidad de 98% a ese resultado. Estas probabilidades cambian continuamente a medida que los operadores reaccionan a nuevos desarrollos. Las acciones del resultado correcto son canjeables por $1 cada una tras la resolución del mercado.

"¿Casos de sarampión en EE. UU. para el 30 de septiembre?" es un mercado recién creado en Polymarket, lanzado el Aug 24, 2026. Como mercado nuevo, esta es tu oportunidad de ser uno de los primeros operadores en establecer las probabilidades y las señales de precio iniciales del mercado. También puedes guardar esta página en marcadores para seguir el volumen y la actividad de trading a medida que el mercado gana tracción.

Para operar en "¿Casos de sarampión en EE. UU. para el 30 de septiembre?", explora los 2 resultados disponibles en esta página. Cada resultado muestra un precio actual que representa la probabilidad implícita del mercado. Para tomar una posición, selecciona el resultado que consideres más probable, elige "Sí" para operar a favor o "No" para operar en contra, introduce tu cantidad y haz clic en "Operar". Si tu resultado elegido es correcto cuando el mercado se resuelve, tus acciones de "Sí" pagan $1 cada una. Si es incorrecto, pagan $0. También puedes vender tus acciones en cualquier momento antes de la resolución.

El favorito actual para "¿Casos de sarampión en EE. UU. para el 30 de septiembre?" es "2900+" con 98%, lo que significa que el mercado asigna una probabilidad de 98% a ese resultado. El siguiente resultado más cercano es "3000+" con 94%. Estas probabilidades se actualizan en tiempo real a medida que los operadores compran y venden acciones. Vuelve con frecuencia o guarda esta página en marcadores.

Las reglas de resolución para "¿Casos de sarampión en EE. UU. para el 30 de septiembre?" definen exactamente qué debe ocurrir para que cada resultado sea declarado ganador, incluyendo las fuentes de datos oficiales utilizadas para determinar el resultado. Puedes revisar los criterios de resolución completos en la sección "Reglas" en esta página sobre los comentarios. Recomendamos leer las reglas cuidadosamente antes de operar, ya que especifican las condiciones exactas, casos especiales y fuentes.